1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Consumables Revenue
1.4 Market Analysis by Type
1.4.1 Global Drug of Abuse (DOA) Testing Consumables Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rapid test kits
1.4.3 Assay kits and reagents
1.4.4 Others
1.5 Market by Application
1.5.1 Global Drug of Abuse (DOA) Testing Consumables Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Laboratories
1.5.4 Workplace
1.5.5 At-Home
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Drug of Abuse (DOA) Testing Consumables Market
1.8.1 Global Drug of Abuse (DOA) Testing Consumables Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Drug of Abuse (DOA) Testing Consumables Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Drug of Abuse (DOA) Testing Consumables Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Drug of Abuse (DOA) Testing Consumables Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Drug of Abuse (DOA) Testing Consumables Sales Volume Market Share by Region (2015-2020)
3.2 Global Drug of Abuse (DOA) Testing Consumables Sales Revenue Market Share by Region (2015-2020)
3.3 North America Drug of Abuse (DOA) Testing Consumables Sales Volume
3.3.1 North America Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.3.2 North America Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Drug of Abuse (DOA) Testing Consumables Sales Volume
3.4.1 East Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.5.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.6.1 South Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.7.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.8.1 Middle East Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.9.1 Africa Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.10.1 Oceania Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.11.1 South America Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.11.2 South America Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Drug of Abuse (DOA) Testing Consumables Sales Volume (2015-2020)
3.12.1 Rest of the World Drug of Abuse (DOA) Testing Consumables Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Drug of Abuse (DOA) Testing Consumables Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Drug of Abuse (DOA) Testing Consumables Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Drug of Abuse (DOA) Testing Consumables Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Drug of Abuse (DOA) Testing Consumables Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Drug of Abuse (DOA) Testing Consumables Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Drug of Abuse (DOA) Testing Consumables Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Drug of Abuse (DOA) Testing Consumables Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Drug of Abuse (DOA) Testing Consumables Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Drug of Abuse (DOA) Testing Consumables Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Drug of Abuse (DOA) Testing Consumables Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Drug of Abuse (DOA) Testing Consumables Sales Volume Market Share by Type (2015-2020)
14.2 Global Drug of Abuse (DOA) Testing Consumables Sales Revenue Market Share by Type (2015-2020)
14.3 Global Drug of Abuse (DOA) Testing Consumables Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Drug of Abuse (DOA) Testing Consumables Consumption Volume by Application (2015-2020)
15.2 Global Drug of Abuse (DOA) Testing Consumables Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Drug of Abuse (DOA) Testing Consumables Business
16.1 Siemens AG
16.1.1 Siemens AG Company Profile
16.1.2 Siemens AG Drug of Abuse (DOA) Testing Consumables Product Specification
16.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Express Diagnostics Int'l
16.2.1 Express Diagnostics Int'l Company Profile
16.2.2 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Consumables Product Specification
16.2.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Thermo Fisher Scientific
16.3.1 Thermo Fisher Scientific Company Profile
16.3.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Specification
16.3.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Merck
16.4.1 Merck Company Profile
16.4.2 Merck Drug of Abuse (DOA) Testing Consumables Product Specification
16.4.3 Merck Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Quest Diagnostics
16.5.1 Quest Diagnostics Company Profile
16.5.2 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Specification
16.5.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Roche
16.6.1 Roche Company Profile
16.6.2 Roche Drug of Abuse (DOA) Testing Consumables Product Specification
16.6.3 Roche Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Abbott
16.7.1 Abbott Company Profile
16.7.2 Abbott Drug of Abuse (DOA) Testing Consumables Product Specification
16.7.3 Abbott Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Bio-Rad
16.8.1 Bio-Rad Company Profile
16.8.2 Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Specification
16.8.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Psychemedics
16.9.1 Psychemedics Company Profile
16.9.2 Psychemedics Drug of Abuse (DOA) Testing Consumables Product Specification
16.9.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Drug of Abuse (DOA) Testing Consumables Manufacturing Cost Analysis
17.1 Drug of Abuse (DOA) Testing Consumables Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
17.4 Drug of Abuse (DOA) Testing Consumables Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Drug of Abuse (DOA) Testing Consumables Distributors List
18.3 Drug of Abuse (DOA) Testing Consumables Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Drug of Abuse (DOA) Testing Consumables (2021-2026)
20.2 Global Forecasted Revenue of Drug of Abuse (DOA) Testing Consumables (2021-2026)
20.3 Global Forecasted Price of Drug of Abuse (DOA) Testing Consumables (2015-2026)
20.4 Global Forecasted Production of Drug of Abuse (DOA) Testing Consumables by Region (2021-2026)
20.4.1 North America Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.3 Europe Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.7 Africa Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.9 South America Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Drug of Abuse (DOA) Testing Consumables Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.2 East Asia Market Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.3 Europe Market Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Countriy
21.4 South Asia Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.5 Southeast Asia Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.6 Middle East Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.7 Africa Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.8 Oceania Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.9 South America Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
21.10 Rest of the world Forecasted Consumption of Drug of Abuse (DOA) Testing Consumables by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer